We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+11.03%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$10.6B
AUM Growth
+$1.17B
Cap. Flow
+$3.01B
Cap. Flow %
28.27%
Top 10 Hldgs %
22.3%
Holding
850
New
52
Increased
273
Reduced
342
Closed
48

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$96.9M
2
MRK icon
Merck
MRK
+$73.5M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$57.1M
4
ILMN icon
Illumina
ILMN
+$40.4M
5
TMO icon
Thermo Fisher Scientific
TMO
+$34.2M

Sector Composition

Rank Sector Weight
1 Healthcare 35.77%
2 Technology 20.35%
3 Consumer Discretionary 9.49%
4 Communication Services 7.69%
5 Financials 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPGI icon
51
S&P Global
SPGI
$126B
$42.5M 0.4%
117,761
-15,909
-12% -$5.61M
SBUX icon
52
Starbucks
SBUX
$118B
$42.5M 0.4%
494,201
+228,478
+86% +$18.2M
ASND icon
53
Ascendis Pharma A/S
ASND
$16.7B
$41.5M 0.39%
269,079
+79,000
+42% +$11.4M
LH icon
54
Labcorp
LH
$25.8B
$41.1M 0.39%
253,934
+12,149
+5% +$1.93M
SPLK
55
DELISTED
Splunk Inc
SPLK
$40.8M 0.38%
216,767
+6,023
+3% +$1.2M
TGTX icon
56
TG Therapeutics
TGTX
$8.4B
$40.2M 0.38%
1,501,489
-45,582
-3% -$1.05M
CSCO icon
57
Cisco
CSCO
$456B
$39.4M 0.37%
1,001,422
-141,736
-12% -$6.18M
INTC icon
58
Intel
INTC
$435B
$38.1M 0.36%
735,082
-177,056
-19% -$9.2M
DG icon
59
Dollar General
DG
$27.8B
$37.2M 0.35%
177,378
+24,936
+16% +$4.9M
LLY icon
60
Eli Lilly
LLY
$1.09T
$37.1M 0.35%
250,802
-39,221
-14% -$6.07M
MA icon
61
Mastercard
MA
$497B
$36.9M 0.35%
109,153
-35,979
-25% -$11.7M
LOW icon
62
Lowe's Companies
LOW
$122B
$36.6M 0.34%
220,804
+42,881
+24% +$6.6M
NEE icon
63
NextEra Energy
NEE
$186B
$35.7M 0.34%
515,132
-22,596
-4% -$1.56M
VSLR
64
DELISTED
VIVINT SOLAR, INC.
VSLR
$35.6M 0.33%
+840,936
New +$21.7M
ORCL icon
65
Oracle
ORCL
$346B
$35.4M 0.33%
592,581
-19,214
-3% -$1.09M
NFLX icon
66
Netflix
NFLX
$301B
$35.3M 0.33%
705,670
+46,630
+7% +$2.32M
PTCT icon
67
PTC Therapeutics
PTCT
$6.25B
$35.1M 0.33%
749,960
-24,000
-3% -$1.18M
TRMB icon
68
Trimble
TRMB
$13.6B
$35M 0.33%
718,521
+326,618
+83% +$15.6M
APLS
69
DELISTED
Apellis Pharmaceuticals
APLS
$34.7M 0.33%
1,148,865
-61,533
-5% -$1.84M
AMAT icon
70
Applied Materials
AMAT
$378B
$33.9M 0.32%
570,734
-38,968
-6% -$2.41M
ON icon
71
ON Semiconductor
ON
$32.8B
$33.9M 0.32%
1,562,618
+318,228
+26% +$6.75M
VMW
72
DELISTED
VMware, Inc
VMW
$33.7M 0.32%
234,915
+47,742
+26% +$6.78M
AWK icon
73
American Water Works
AWK
$27B
$33.6M 0.32%
231,618
+10,192
+5% +$1.44M
EMR icon
74
Emerson Electric
EMR
$85B
$33.5M 0.31%
510,570
+47,328
+10% +$3.12M
ALL icon
75
Allstate
ALL
$70.1B
$33.4M 0.31%
354,605
+9,255
+3% +$863K

Similar funds

Candriam SCA's Q3 2020 Portfolio in Review

As of Q3 2020, Candriam SCA held 850 positions worth $10.6B, up 12% from $9.47B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA deployed $3.01B of net new capital in Q3 2020, opening 52 new positions and adding to 273 existing holdings. Its largest new stake was VIVINT SOLAR, INC.: 840,936 shares worth $35.6M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 35% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $57.2M trimmed.

  • Candriam SCA's largest Q3 2020 buy was VIVINT SOLAR, INC.: 840,936 shares worth $35.6M.
  • Candriam SCA added most to Amgen in Q3 2020, an estimated $96.9M increase.
  • Candriam SCA's biggest Q3 2020 reduction was Apple, cutting an estimated $57.2M.
  • Candriam SCA fully exited G1 Therapeutics, Inc. Common Stock in Q3 2020, selling an estimated $21.1M.
  • Candriam SCA's ten largest holdings make up 22% of its $10.6B portfolio in Q3 2020.
  • Candriam SCA opened 52 new positions and closed 48 in Q3 2020.
  • Candriam SCA's portfolio value rose 12% quarter-over-quarter to $10.6B.

Based on Candriam SCA's 13F filing for Q3 2020, filed 19 Oct 2020.